Verrica Pharmaceuticals (VRCA) Invested Capital (2017 - 2026)

Verrica Pharmaceuticals' Invested Capital history runs 9 years deep, the most recent figure standing at $942000.0 for Q1 2026.

• In Q1 2026, Invested Capital fell 92.65% year-over-year to $942000.0; the TTM figure through Mar 2026 stood at $15.7 million (down 47.03% YoY), while the FY2025 annual figure was $1.0 million, down 91.9% from the prior year.
• Invested Capital for Q1 2026 stood at $942000.0, down from $1.0 million in the prior quarter.
• The five-year high for Invested Capital was $42.3 million in Q2 2022, with the low at $942000.0 in Q1 2026.
• The 4-year median for Invested Capital is $12.7 million (2025), against an average of $14.4 million.
• The sharpest annual moves came in 2022 and 2026: Invested Capital advanced 3.27% in 2022, then sank 92.65% in 2026.
• Verrica Pharmaceuticals' Invested Capital stood at $42.3 million in 2022, then plunged by 69.41% to $12.9 million in 2024, then sank by 91.9% to $1.0 million in 2025, then retreated by 10.11% to $942000.0 in 2026.
• Business Quant data shows VRCA's Invested Capital at $942000.0 in Q1 2026, $1.0 million in Q4 2025, and $995000.0 in Q3 2025.